Capricor Therapeutics, Inc. (CAPR) — Analyst estimates
Consensus analyst estimates for Capricor Therapeutics, Inc. — earnings, revenue, and price targets.
| Fiscal Year | Revenue Forecast | EPS Forecast | analysts |
|---|---|---|---|
| 2026 | 50.45M | 0.24 | 4 |
| 2027 | 32.93M | -0.11 | 2 |
| 2028 | 248.53M | 1.75 | 4 |
| 2029 | 371.27M | 3.35 | 2 |
| 2030 | 599.03M | 5.96 | 2 |
Consensus analyst estimates by fiscal year.